Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.64 USD | -2.65% | +1.14% | -2.83% |
May. 08 | Precision BioSciences, Inc. announced that it has received $0.3 million in funding | CI |
Apr. 30 | Guggenheim Starts Precision BioSciences With Buy Rating, $19 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
- Stock Market
- Equities
- DTIL Stock
- News Precision BioSciences, Inc.
- Precision BioSciences to Present Preclinical Gene Editing Data on Hepatitis B Program Dec. 6